共 16 条
[1]
Presence of significant synovitis in rheumatoid arthritis patients with disease‐modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression.[J].A. K.Brown;M. A.Quinn;Z.Karim;P. G.Conaghan;C. G.Peterfy;E.Hensor;R. J.Wakefield;P. J.O'Connor;P.Emery.Arthritis & Rheumatism.2006, 12
[2]
Single and combined inhibition of tumor necrosis factor; interleukin‐1; and RANKL pathways in tumor necrosis factor–induced arthritis: Effects on synovial inflammation; bone erosion; and cartilage destruction.[J].JochenZwerina;SilviaHayer;MakiyehTohidast‐Akrad;HelgaBergmeister;KurtRedlich;UlrichFeige;ColinDunstan;GiorgosKollias;GünterSteiner;JosefSmolen;GeorgSchett.Arthritis & Rheumatism.2004, 1
[3]
Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management
[J].
LANCET INFECTIOUS DISEASES,
2003, 3 (03)
:148-155
Gardam, MA
;
Keystone, EC
;
Menzies, R
;
Manners, S
;
Skamene, E
;
Long, R
;
Vinh, DC
.
[4]
Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway
[J].
GASTROENTEROLOGY,
2001, 121 (05)
:1145-1157
Lügering, A
;
Schmidt, M
;
Lügering, N
;
Pauels, HG
;
Domschke, W
;
Kucharzik, T
.
[5]
Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis
[J].
SEMINARS IN ARTHRITIS AND RHEUMATISM,
2000, 30 (03)
:196-208
Schiff, MH
;
Whelton, A
.
[6]
Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions.[J].Bernard J. Scallon;Maria Arevalo Moore;Han Trinh;David M. Knight;John Ghrayeb.Cytokine.1995, 3
[7]
Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins.[J].Bernard J. Scallon;Han Trinh;Mark Nedelman;Fionula M. Brennan;Marc Feldmann;John Ghrayeb.Cytokine.1995, 8
[8]
[9]
[10]